- Home
- NXPLW vs FULC Comparison
NXPLW vs FULC Comparison
Compare NXPLW & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPLW
- FULC
- Stock Information
- Founded
- NXPLW N/A
- FULC 2015
- Country
- NXPLW United States
- FULC United States
- Employees
- NXPLW 166
- FULC N/A
- Industry
- NXPLW Telecommunications Equipment
- FULC Biotechnology: Pharmaceutical Preparations
- Sector
- NXPLW Telecommunications
- FULC Health Care
- Exchange
- NXPLW Nasdaq
- FULC Nasdaq
- Market Cap
- NXPLW N/A
- FULC N/A
- IPO Year
- NXPLW N/A
- FULC 2019
- Fundamental
- Price
- NXPLW N/A
- FULC $3.29
- Analyst Decision
- NXPLW
- FULC Hold
- Analyst Count
- NXPLW 0
- FULC 8
- Target Price
- NXPLW N/A
- FULC $6.57
- AVG Volume (30 Days)
- NXPLW 6.4K
- FULC 326.8K
- Earning Date
- NXPLW 03-31-2025
- FULC 05-12-2025
- Dividend Yield
- NXPLW N/A
- FULC N/A
- EPS Growth
- NXPLW N/A
- FULC N/A
- EPS
- NXPLW N/A
- FULC N/A
- Revenue
- NXPLW $66,482,000.00
- FULC $80,000,000.00
- Revenue This Year
- NXPLW N/A
- FULC N/A
- Revenue Next Year
- NXPLW N/A
- FULC N/A
- P/E Ratio
- NXPLW N/A
- FULC N/A
- Revenue Growth
- NXPLW 179.89
- FULC 2752.05
- 52 Week Low
- NXPLW $0.25
- FULC $2.32
- 52 Week High
- NXPLW $0.26
- FULC $10.13
- Technical
- Relative Strength Index (RSI)
- NXPLW N/A
- FULC 58.82
- Support Level
- NXPLW N/A
- FULC $2.49
- Resistance Level
- NXPLW N/A
- FULC $3.00
- Average True Range (ATR)
- NXPLW 0.00
- FULC 0.25
- MACD
- NXPLW 0.00
- FULC 0.08
- Stochastic Oscillator
- NXPLW 0.00
- FULC 97.01
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.